Abstract:Importance Salt substitution has been reported to be a cost-saving sodium reduction strategy that has not yet been replicated in different contexts. Objective To estimate the cost-effectiveness of sodium reduction strategies within the DECIDE-Salt trial. Design, Setting, and Participants The DECIDE-Salt trial cluster randomized in a 1:1:1:1 ratio 48 eldercare facilities in China into 4 groups for evaluation of 2 sodium reduction strategies for 2 years: 1 with both strategies, 2 with either strategy, and 1 with neither strategy. The trial was conducted from September 25, 2017, through October 24, 2020. Interventions The 2 intervention strategies were replacing regular salt with salt substitute and progressively restricting salt supply to kitchens. Main Outcomes and Measures The main outcomes included per-participant costs of intervention implementation and medical treatments for hypertension and major adverse cardiovascular events (MACEs) against mean reductions in systolic blood pressure, hypertension prevalence, MACE incidence, and mortality. The incremental cost-utility ratio was then assessed as the additional mean cost per quality-adjusted life-year gained. Analyses were conducted separately for each strategy, comparing groups assigned and not assigned the test strategy. Disease outcomes followed the intention-to-treat principle and adopted different models as appropriate. One-way and probabilistic sensitivity analyses were conducted to explore uncertainty, and data analyses were performed between August 13, 2022, and April 5, 2023. Results A total of 1612 participants (1230 males [76.3%]) with a mean (SD) age of 71.0 (9.5) years were enrolled. Replacing regular salt with salt substitute reduced mean systolic blood pressure by 7.14 (95% CI, 3.79-10.48) mm Hg, hypertension prevalence by 5.09 (95% CI, 0.37-9.80) percentage points, and cumulative MACEs by 2.27 (95% CI, 0.09-4.45) percentage points. At the end of the 2-year intervention, the mean cost was $25.95 less for the salt substitute group than the regular salt group due to substantial savings in health care costs for MACEs (mean [SD], $72.88 [$9.11] vs $111.18 [$13.90], respectively). Sensitivity analysis showed robust cost savings. By contrast, the salt restriction strategy did not show significant results. If the salt substitution strategy were rolled out to all eldercare facilities in China, 48 101 MACEs and 107 857 hypertension cases were estimated to be averted and $54 982 278 saved in the first 2 years. Conclusions and Relevance The findings of this cluster randomized clinical trial indicate that salt substitution may be a cost-saving strategy for hypertension control and cardiovascular disease prevention for residents of eldercare facilities in China. The substantial health benefit savings in preventing MACEs and moderate operating costs offer strong evidence to support the Chinese government and other countries in planning or implementing sodium intake reduction and salt substitute campaigns.

Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities

Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities: the DECIDE-Salt Cluster Randomized Clinical Trial.

Cost-Effectiveness of Salt Substitute and Supply Restriction in Eldercare Facilities

Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial

Impact of Salt Substitute and Stepwise Reduction of Salt Supply on Blood Pressure in Residents in Senior Residential Facilities: Design and Rationale of the DECIDE-Salt Trial

Impact of Salt Substitute and Stepwise Reduction of Salt Supply on Blood Pressure in the Elderly in Nursing Homes (Decide-Salt Trial): Protocol and Baseline Characteristics (P13-022-19).

Experience with 2 Years' Intervention to Progressively Reduce Salt Supply to Kitchens in Elderly Care Facilities-Challenges and Further Research: Post Hoc Analysis of the DECIDE-Salt Randomized Clinical Trial.

Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS)

Cost-Effectiveness of a Household Salt Substitution Intervention: Findings from 20 995 Participants of the Salt Substitute and Stroke Study

Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults

Salt Substitution: A Low-Cost Strategy for Blood Pressure Control among Rural Chinese. A Randomized, Controlled Trial

PS 18-18 Economic Evaluation of a School-Based Education Programme to Reduce Salt Intake in Children and Their Families in China

Cost and Cost-Effectiveness of a School-Based Education Program to Reduce Salt Intake in Children and Their Families in China

Effect of Salt Substitution on Cardiovascular Events and Death.

Factors Associated with the Use of a Salt Substitute in Rural China.

Protocol for the economic evaluation of the China Salt Substitute and Stroke Study (SSaSS)

The Effects of A Community-Based Sodium Reduction Program in Rural China - A Cluster-Randomized Trial

Rationale, Design, and Baseline Characteristics of the Salt Substitute and Stroke Study (ssass)—a Large-Scale Cluster Randomized Controlled Trial

Effects and individual response of salt substitute intervention on blood pressure in a high-risk stroke population: findings from 4200 participants of the China Salt Substitute and Stroke Study

Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensive Adults

Interim Effects of Salt Substitution on Urinary Electrolytes and Blood Pressure in the China Salt Substitute and Stroke Study (Ssass)